13-109164925-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001198950.3(MYO16):c.5189G>A(p.Ser1730Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000698 in 1,433,348 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001198950.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYO16 | NM_001198950.3 | c.5189G>A | p.Ser1730Asn | missense_variant | 33/35 | ENST00000457511.7 | NP_001185879.1 | |
MYO16-AS1 | NR_047700.1 | n.361-834C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO16 | ENST00000457511.7 | c.5189G>A | p.Ser1730Asn | missense_variant | 33/35 | 1 | NM_001198950.3 | ENSP00000401633 | A2 | |
MYO16 | ENST00000356711.7 | c.5123G>A | p.Ser1708Asn | missense_variant | 33/35 | 1 | ENSP00000349145 | P2 | ||
MYO16-AS1 | ENST00000439299.1 | n.391-834C>T | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.98e-7 AC: 1AN: 1433348Hom.: 0 Cov.: 29 AF XY: 0.00000140 AC XY: 1AN XY: 712696
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 01, 2023 | The c.5189G>A (p.S1730N) alteration is located in exon 33 (coding exon 33) of the MYO16 gene. This alteration results from a G to A substitution at nucleotide position 5189, causing the serine (S) at amino acid position 1730 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.